BCL2L1 and prostate cancer: PGG inhibited STAT3 Tyr705 phosphorylation in the prostate cancer DU145 cell line, thereby downregulating STAT3 transcriptional targets, such as Bcl-XL and Mcl-1, which decreased cell viability and increased caspase-mediated apoptosis.